Investors

10 downloads 298 Views 1MB Size Report
May 8, 2017 - in-licensing staff from major corporations in the life science and ... funding to startup companies. ... f
MONDAY OF BIO WEEK JUNE 19, 2017 | SAN DIEGO, CA

INVESTORS RESI San Diego will bring together 400+ active healthcare investors and 400+ fundraising CEOs (a 1:1 ratio) from around the globe.

OTHER CONFERENCES Investors You'll Find at RESI Investment staff involved directly in an early stage life science or healthcare venture capital or private equity fund.

Groups Defined as "Investors" at Other Conferences But Not at RESI

Investment staff at a family office or private wealth fund that invests in life sciences.

Broker dealers, investment bankers or merchant bankers.

External innovation, early stage partnering or in-licensing staff from major corporations in the life science and healthcare industry.

Venture debt investors and other providers of debt financing.

Active life science angels or executive staff at angel organizations that invest in early stage life science companies.

Service providers/consultants to the life science or healthcare industry. THEY ARE NOT INVESTORS.

Investment staff and executives at nonprofit organizations, venture philanthropy/impact investment firms or patient groups that provide funding to startup companies.

Firms that provide services and/or charge a fee to life science companies in exchange for introductions to investors.

Senior management or investment staff from a pension, endowment, foundation or employee benefit plan currently invested in life science.

Firms that provide management or development services in return for equity.

INVESTMENT SECTOR Investors at RESI San Diego will be 22% looking for 34% technologies across 19% Therapeutics, Medical Device, 25% Diagnostics and Healthcare IT Therapeutics Diagnostics

Medical Device Healthcare IT

8% 9% 16%

Therapeutics Diagnostics

67%

A large proportion of Investors at other conferences are mostly investing in Therapeutics

Medical Device Healthcare IT

CONFIRMED INVESTORS

400+ Expected on June 19th Click on the Logos to Learn More As of May 8th, 2017

RESI San Diego focuses on the diverse breadth (10 categories) of active early stage healthcare investors that LSN tracks. Investor Type

Percentage

Large Pharma/Medtech

23%

Venture Capital

20%

Family Office/Private Wealth

14%

Corporate Venture Capital

13%

Angel

10%

Government Organization

9%

Endowments/Foundations

3%

Private Equity

3%

Institutional Alternative Investor

3%

Hedge Fund

2%

Register Now For more information, please contact the RESI team at [email protected] or (617) 600-0668